Form 4 for BIIB Biogen
Accepted 2022-07-06 00:00:00 ET · period of report 2022-07-01 · accession 0001127602-22-019021 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-07-06 | 2022-07-01 | BIIB | Kramer Robin | CAO | F - Tax | $210.63 | -74 | 2,018 | -4% | -$15.6K |
| D | 2022-07-06 | 2022-07-01 | BIIB | Kramer Robin | CAO | M - OptEx | $0.00 | +252 | 2,092 | +14% | $0 |
| D | 2022-07-06 | 2022-07-01 | BIIB | Kramer Robin | CAO | M - OptEx | $0.00 | -252 | 252 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-07-01 | F | D | 74 | $210.63 | 2,017.75 | D | — | — | |
| 2 | Common | Common Stock | 2022-07-01 | M | A | 252 | $0.00 | 2,091.75 | D | — | — | (F1) Includes 102.4003 shares acquired under the Biogen Inc. employee stock purchase plan. |
| 3 | Derivative | Restricted Stock Unit | 2022-07-01 | M | D | 252 | $0.00 | 252 | D | $0.00 · — to 2023-07-01 | 252 Common Stock | (F2) The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 07/01/2020. |